Myeloma Cytogenetic Risk — Targeted Therapies, Trials & Pipeline

FISH/cytogenetic risk stratification in multiple myeloma — high-risk features such as del(17p), t(4;14), and t(14;16) portend inferior outcomes and inform intensity of frontline and maintenance therapy.